Allison Staley, MD, MPH
Obesity influences the development and management of gynecologic cancer through several mechanisms, including hormonal, inflammatory, and metabolic pathways. Prospective data demonstrate a significantly increased risk of mortality from cancers of the breast, uterus, cervix, and ovary in women who are considered obese.1
With nearly 40% of the adult population in the Unites States classified as obese (body mass index [BMI] ≥30kg/m2
), gynecologic oncologists must be ready to address the specific needs and considerations for this population, including for patients who have entered survivorship.
... to read the full story